500 MOONS LIMITED

Company number 13836912 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

500 MOONS LIMITED - Analysis Report

Company Number: 13836912

Analysis Date: 2025-07-20 11:36 UTC

Financial Health Assessment of 500 MOONS LIMITED


1. Financial Health Score: D

Explanation:
The company shows signs of severe financial strain with extremely limited net assets and minimal working capital. While not in immediate insolvency, the financial "vital signs" are weak, indicating a fragile financial condition that requires urgent attention to avoid distress.


2. Key Vital Signs

Metric 2024 Value (£) Interpretation
Current Assets 34,369 Reasonable cash and receivables for a micro-entity.
Current Liabilities 34,363 Almost equal to current assets, indicating tight liquidity.
Net Current Assets 6 Critical symptom of "working capital" deficiency. Almost no buffer for short-term obligations.
Net Assets (Shareholders’ Funds) 6 Extremely low equity base, indicating minimal retained earnings or capital.
Employee Count 1 Very small operation, likely founder-led or sole trader in limited company form.
Filing Status Up to date Compliance with statutory requirements is a positive sign.

3. Diagnosis

  • Liquidity / Working Capital: The company’s current assets just cover its current liabilities with a net working capital of only £6 in 2024, down from £1,205 in 2023. This is akin to a patient whose vital signs are barely stable — any unexpected expense or drop in receivables could cause liquidity failure.

  • Capital Structure: Net assets have diminished drastically from £755 in 2023 to just £6 in 2024. This signals a loss of retained earnings or shareholder value and points toward operational losses or distributions exceeding income. The equity base is essentially non-existent, leaving no cushion to absorb shocks.

  • Scale & Operations: With only one employee, the company operates at a micro scale, which limits economies of scale but also means fixed overheads are likely low. However, the minimal working capital suggests limited operational runway.

  • Profitability & Cash Flow: No explicit profit & loss data is provided, but the erosion of net assets and working capital strongly suggests operating losses or cash flow difficulties.

  • Compliance: The company is current on accounts and confirmation statement filings, which is a positive "clinical" sign of governance and regulatory compliance.

  • Ownership & Control: Single shareholder/director with 75-100% control indicates centralized decision-making but also potential risk if oversight or external advice is limited.


4. Recommendations

  • Immediate Cash Flow Management:
    Introduce rigorous cash flow forecasting and management to prevent short-term liquidity crises. Treat the current working capital level as a critical symptom needing urgent correction.

  • Capital Injection or Funding:
    Consider a capital injection from the shareholder or external financing to rebuild equity and provide a financial buffer. This will improve the "immune system" of the business against shocks.

  • Cost Control and Revenue Enhancement:
    Review operational expenses and focus on increasing revenues or diversifying income streams. The goal is to restore profitability and rebuild retained earnings.

  • Financial Planning & Monitoring:
    Implement monthly financial reviews to track "vital signs" such as liquidity ratios, cash flow, and profitability metrics to detect early warning signals.

  • Seek Professional Advice:
    Engage an accountant or financial advisor to assist with budgeting, financial restructuring if necessary, and strategic planning to improve financial resilience.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.